Formed by the law of 31 December 2012, Bpifrance (a public sector investment bank) is the outcome of the merger between OSEO, the FSI, CDC Entreprises and FSI Régions. Its two shareholders are the French state and the Caisse des Dépôts bank. Its object is to support businesses (SMEs, medium-sized enterprises and larger companies of a strategic importance to the French economy), from start-up through to stock market flotation, by providing loans, guarantees and equity. Bpifrance also provides enhanced support and backing for innovation, export, and external growth. With its 42 regional offices, it is a one-stop shop for entrepreneurs in each region for all their finance and investment needs. Bpifrance is also an actor in the EU public debate and participates in the management of several European funding programmes. www.bpifrance.fr - Follow us on Twitter: @bpifrance

The French Alternative Energies and Atomic Energy Commission (CEA) is a key player in research, development and innovation in four main areas: defence and security, low carbon energies (nuclear and renewable energies), technological research for industry, fundamental research in the physical sciences and life sciences. Drawing on its widely acknowledged expertise, the CEA actively participates in collaborative projects with a large number of academic and industrial partners. The CEA is established in nine centers spread throughout France. It works in partnership with many other research bodies, local authorities and universities. Within this context, the CEA is a stakeholder in a series of national alliances set up to coordinate French research in energy (ANCRE), life sciences and health (AVIESAN), digital science and technology (ALLISTENE), environmental sciences (AllEnvi) and human and social sciences (ATHENA).

CNRS Innovation, is the national technology transfer office of CNRS, one of the world’s leading research institutions. Affiliate of the CNRS and Bpifrance, CNRS Innovation puts its 25 years of experience at the service of the tranfers to the industry of technologies arising from CNRS research laboratories. From the evaluation of your technologies to the elaboration of the intellectual property and transfer strategy.

EuroQuity is the digital ecosystem created by Bpifrance to put growth companies in contact with development partners and with investors in particular.We believe that your company's exposure and reputation are the keys to finding new partners. We provide the resources you need to bring together all of your company's points of interest in a unique, dynamic system.

Inria, the French research institute for digital sciences, promotes scientific excellence and technology transfer to maximise its impact. It employs 2,400 people. Its 200 agile project teams, generally with academic partners, involve more than 3,000 scientists in meeting the challenges of computer science and mathematics, often at the interface of other disciplines. Inria works with many companies and has assisted in the creation of over 160 startups. It strives to meet the challenges of the digital transformation of science, society and the economy.

Inserm Transfert Initiative (ITI) was created under the initiative of Inserm, the French National Institute of Health and Medical Research. Inserm is a biomedical and public health research institution with nearly 15,000 researchers, engineers, technicians and post-doctoral students as well as over 300 laboratories. It is the number one academic and clinical research organisation dedicated to human health in Europe.

In France, SATTs have the challenging mission to accelerate the transformation of French research into innovations. SATT aims to enhance the value of publically funded research and to accelerate the process of technology transfer towards industry. SATTs evaluates, markets and licenses out the technologies from French Universities and Public Research Organisations. The Technology Transfer Accelerator Organisations (Sociétés d’Accélération de Transfert de Technologie, or SATT) are French private TTOs, shared between several public research organizations, created to develop and commercialize research results to be transformed into innovative products.